Auro Laboratories Limited (BOM:530233)
230.15
+14.60 (6.77%)
At close: Jan 21, 2026
Auro Laboratories Revenue
Auro Laboratories had revenue of 88.37M INR in the quarter ending September 30, 2025, with 184.94% growth. This brings the company's revenue in the last twelve months to 221.88M, down -42.91% year-over-year. In the fiscal year ending March 31, 2025, Auro Laboratories had annual revenue of 193.98M, down -63.83%.
Revenue (ttm)
221.88M
Revenue Growth
-42.91%
P/S Ratio
6.03
Revenue / Employee
3.08M
Employees
72
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 193.98M | -342.37M | -63.83% |
| Mar 31, 2024 | 536.35M | 7.41M | 1.40% |
| Mar 31, 2023 | 528.94M | 20.28M | 3.99% |
| Mar 31, 2022 | 508.66M | -33.86M | -6.24% |
| Mar 31, 2021 | 542.52M | 104.61M | 23.89% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.28B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
Auro Laboratories News
- 1 year ago - Shaan Jain resigns as CFO of Auro Laboratories, effective December 18, 2024 - Business Upturn